Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02413970 · ClinicalTrials.gov registry record · NA
Inspire® Post-Approval Study / Protocol Number 2014-001
A NA study of Obstructive Sleep Apnea, sponsored by Inspire Medical Systems.
- Active
- Registry status
- NA
- Development phase
- 127
- Enrollment target
- 14
- Study locations
NCT02413970: Active NA study of Obstructive Sleep Apnea, sponsored by Inspire Medical Systems.
NCT02413970 is a NA study of Obstructive Sleep Apnea that is active but no longer recruiting, run by Inspire Medical Systems. The registered enrollment target is 127 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (43% lower). The trial reports 14 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02413970, a NA study of Obstructive Sleep Apnea, is active but no longer recruiting, sponsored by Inspire Medical Systems.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 127 participants
- Enrollment target
- 14
- Study locations
Study Summary
The purpose of this study is to obtain additional long-term safety and efficacy data on the use of Inspire therapy.
Conditions Studied
Interventions
- DEVICE Inspire® UAS System
Study Locations (14)
Ohio
- The Christ Hospital - Cincinnati
- University Hospitals - Cleveland
- Cleveland Clinic Foundation - Cleveland
Pennsylvania
- University of Pennsylvania, Division of Sleep Medicine - Philadelphia
- Thomas Jefferson University and Hospital - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Florida
- South Miami Hospital - Miami
- Tampa General Hospital - Tampa
Alabama
- The University of Alabama at Birmingham Medical Center - Birmingham
California
- University of Southern California - Los Angeles
Kansas
- The University of Kansas Medical Center - Kansas City
Kentucky
- Kentucky Research Group - Louisville
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2015-05 |
| Est. Completion | 2025-06 |
| Phase | NA |
What the registry record for NCT02413970 still lists
NCT02413970 is an interventional study that assigns participants to a tested intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Inspire® UAS System is the first listed.
NCT02413970 lists 14 locations in 9 states (Ohio, Pennsylvania, Florida).
Frequently Asked Questions
What is clinical trial NCT02413970 about?
NCT02413970 is a clinical study titled "Inspire® Post-Approval Study / Protocol Number 2014-001". The purpose of this study is to obtain additional long-term safety and efficacy data on the use of Inspire therapy.
What is the current status of trial NCT02413970?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 127 participants. The study started on 2015-05. Estimated completion is 2025-06.
What conditions does trial NCT02413970 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT02413970?
The interventions under investigation include: Inspire® UAS System (DEVICE).
Who is sponsoring clinical trial NCT02413970?
This trial is sponsored by Inspire Medical Systems, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02413970 being conducted?
This trial has 14 study locations across Alabama, California, Florida, Kansas, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02413970's enrollment target sits among peer trials
127 59th of 155 higher than 97 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia